Fusion RT variants for RNA structure interference
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current reverse transcriptase enzymes, such as wild-type MMLV, face challenges with thermostability and activity interference from RNA secondary structures and inhibitors, leading to reduced performance in cDNA synthesis reactions, especially at higher temperatures and in cell lysates.
Innovation Solution
Engineered fusion reverse transcriptases with specific mutations and DNA binding domains, such as M39V, M66L, and E69K, are developed to enhance thermostability and activity, incorporating archaeal or single-stranded DNA binding domains to improve processivity, template switching efficiency, and chemical tolerance.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If higher reaction temperature is used to remove RNA secondary structure, then RNA secondary structure interference is reduced, but reverse transcriptase enzyme activity decreases
Solution Approach 1:
The patent applies parameter changes by modifying the reverse transcriptase enzyme through site-directed mutagenesis at specific residues (M39, M66, E69, L435, D449, D524, E607, D653, L671) to alter the enzyme's thermal stability parameters. This allows the enzyme to maintain activity at higher temperatures (50-60°C) that effectively denature RNA secondary structures, thus resolving the contradiction between removing RNA secondary structure interference and maintaining enzyme activity.
Solution Approach 2:
The patent creates a composite enzyme structure by introducing multiple point mutations across different regions of the reverse transcriptase protein. These mutations work synergistically to enhance thermostability while preserving catalytic function, effectively creating a composite functional profile that combines heat resistance with enzymatic activity at temperatures that eliminate RNA secondary structure problems.
2Reliability
If wild-type MMLV reverse transcriptase is used, then enzyme activity is maintained at lower temperatures, but performance is reduced in the presence of inhibitors and at higher temperatures
Solution Approach 1:
The patent changes the physiological parameters of the reverse transcriptase enzyme through targeted mutations that expand its operational temperature range and enhance its resistance to inhibitors. The mutations at residues M39, M66, E69, and others modify the enzyme's structural stability and active site properties, allowing it to function effectively in conditions where wild-type enzyme fails, thus improving adaptability without completely sacrificing low-temperature activity.
3Productivity
If low volume reactions are used, then reaction efficiency is improved, but reverse transcriptase activity is negatively impacted
Solution Approach 1:
The patent modifies the enzyme's parameters to enhance its stability and activity in concentrated conditions typical of low-volume reactions. The mutations improve the enzyme's ability to function at higher local concentrations and in the presence of reaction components that may be more concentrated in small volumes, thereby maintaining reliability while supporting high-productivity low-volume reaction formats.
Data Source
AI summary
The application provides compositions including engineered fusion reverse transcriptases with at least one altered reverse-transcriptase related activity. The engineered fusion reverse transcriptases or reverse transcription enzymes unexpectedly exhibit one or more altered reverse transcriptase related activities such as but not limited to altered template switching efficiency, altered transcription efficiency or both.